{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T01:47:15Z","timestamp":1777772835645,"version":"3.51.4"},"reference-count":23,"publisher":"BMJ","issue":"21","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2022,4,27]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>A sizeable proportion of patients with secondary mitral regurgitation (SMR) do not receive guideline-directed medical therapy (GDMT) for heart failure (HF). We investigated the association between the use of GDMT and mortality in patients with SMR who underwent transcatheter edge-to-edge repair (TEER).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analysed patients with SMR and a left ventricular ejection fraction of &lt;50% who underwent TEER at three centres. According to current HF guidelines, GDMT was defined as triple therapy consisting of beta-blockers, renin\u2013angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists (MRAs). Patients were divided into two groups: GDMT and non-GDMT groups. We calculated the propensity scores and carried out inverse probability of treatment weighting (IPTW) analyses to compare 2-year mortality between the two groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 463 patients, 228 (49.2%) were treated with GDMT upon discharge. IPTW-adjusted Kaplan-Meier curve showed patients with GDMT had a lower incidence of mortality than those without GDMT (19.8% vs 31.1%, p=0.011). In IPTW-adjusted Cox proportional hazards analysis, GDMT was associated with a reduced risk of 2-year mortality (HR: 0.58; 95% CI: 0.35 to 0.95; p=0.030), which was consistent among clinical subgroups. Moreover, patients with GDMT had a higher rate of left ventricular reverse remodelling at 1 year after TEER than those without GDMT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>GDMT, defined as triple therapy consisting of beta-blockers, RAS inhibitors and MRAs, was associated with a reduced risk of 2-year mortality after TEER for SMR. Optimisation of medical therapy is crucial to improve clinical outcomes in patients undergoing TEER for SMR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2022-320826","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T13:20:35Z","timestamp":1654608035000},"page":"1722-1728","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-8689","authenticated-orcid":false,"given":"Tetsu","family":"Tanaka","sequence":"first","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4035-1142","authenticated-orcid":false,"given":"Refik","family":"Kavsur","sequence":"additional","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Spieker","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital of D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Iliadis","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Metze","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birthe M","family":"Brachtendorf","sequence":"additional","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Horn","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital of D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Zachoval","sequence":"additional","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0060-1052","authenticated-orcid":false,"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital of D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Baldus","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Westenfeld","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital of D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Pfister","sequence":"additional","affiliation":[{"name":"Heart Center, Department of Cardiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Ulrich","family":"Becher","sequence":"additional","affiliation":[{"name":"Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"2025091923533395000_108.21.1722.1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2017.2976","article-title":"Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis","volume":"2","author":"Sannino","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2025091923533395000_108.21.1722.2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025091923533395000_108.21.1722.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.03.016"},{"key":"2025091923533395000_108.21.1722.4","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2025091923533395000_108.21.1722.5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2025091923533395000_108.21.1722.6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","article-title":"Refining the prognostic impact of functional mitral regurgitation in chronic heart failure","volume":"39","author":"Goliasch","year":"2018","journal-title":"Eur Heart J"},{"key":"2025091923533395000_108.21.1722.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.06.015"},{"key":"2025091923533395000_108.21.1722.8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2025091923533395000_108.21.1722.9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"2025091923533395000_108.21.1722.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2025091923533395000_108.21.1722.11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ejhf.1343","article-title":"Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry","volume":"21","author":"Adamo","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025091923533395000_108.21.1722.12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2188\/jea.JE20210145","article-title":"Using propensity scores for causal inference: pitfalls and tips","volume":"31","author":"Shiba","year":"2021","journal-title":"J Epidemiol"},{"key":"2025091923533395000_108.21.1722.13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/1536867X1401400410","article-title":"Analysis of partially observed clustered data using generalized estimating equations and multiple imputation","volume":"14","author":"Aloisio","year":"2014","journal-title":"Stata J"},{"key":"2025091923533395000_108.21.1722.14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"2025091923533395000_108.21.1722.15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ejhf.2002","article-title":"Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair","volume":"23","author":"Hagn\u00e4s","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2025091923533395000_108.21.1722.16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2025091923533395000_108.21.1722.17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(99)00059-4","article-title":"Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure","volume":"83","author":"Lowes","year":"1999","journal-title":"Am J Cardiol"},{"key":"2025091923533395000_108.21.1722.18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ehf2.12042","article-title":"Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy","volume":"2","author":"He","year":"2015","journal-title":"ESC Heart Fail"},{"key":"2025091923533395000_108.21.1722.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.079"},{"key":"2025091923533395000_108.21.1722.20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC Heart Fail"},{"key":"2025091923533395000_108.21.1722.21","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"2025091923533395000_108.21.1722.22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"2025091923533395000_108.21.1722.23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-320826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:53:45Z","timestamp":1758351225000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-320826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":23,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,10,13]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/heartjnl-2022-320826"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-320826","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]}}}